Xiaona Su
Daping, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Differential effect of tumor budding on the benefit of adjuvant chemotherapy in stage II colorectal cancer: a retrospective observational study.
Journal: Journal of gastrointestinal oncology
Published: April 17, 2024
Prognosis value of circulating tumor cell PD‑L1 and baseline characteristics in patients with NSCLC treated with immune checkpoint inhibitors plus platinum‑containing drugs.
Journal: Oncology letters
Published: October 17, 2023
The effect of Inc parameter on VMAT radiotherapy plans quality for rectal cancer using Monaco TPS.
Journal: Journal of applied clinical medical physics
Published: August 24, 2023
Case Report: Genetic and immune microenvironmental characteristics of a rectal cancer patient with MSS/PD-L1-negative recurrent hepatopulmonary metastasis who achieved complete remission after treatment with PD-1 inhibitor.
Journal: Frontiers in immunology
Published: March 31, 2023
Knowledge and attitudes of medical and pharmacy students about pharmacogenomics: a systematic review and meta-analysis.
Journal: The pharmacogenomics journal
Published: January 19, 2023
A retrospective study of postoperative targeted therapy in ALK-positive lung cancer.
Journal: Scientific reports
Published: December 24, 2022
Co-Occurring Alteration of NOTCH and DDR Pathways Serves as Novel Predictor to Efficacious Immunotherapy in NSCLC.
Journal: Frontiers in oncology
Published: January 27, 2021
Thymidylate synthase gene polymorphism predicts disease free survival in stage II-III rectal adenocarcinoma patients receiving adjuvant 5-FU-based chemotherapy.
Journal: Chinese clinical oncology
Published: May 22, 2018
FGFR inhibitor AZD4547 can enhance sensitivity of esophageal squamous cell carcinoma cells with epithelial‑mesenchymal transition to gefitinib.
Journal: Oncology reports
Published: August 30, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026